FORT LEE, N.J., June 26 /PRNewswire-FirstCall/ -- Alpharma Inc. today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.045 per common share. The dividend is payable July 28, 2006 to all shareholders on record as of July 14, 2006.

Alpharma Inc. (NYSE: ALO) is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 60 countries. Alpharma has a growing branded franchise in the chronic pain market with its morphine-based extended release KADIAN(R) product. In addition, Alpharma is among the world's leading producers of several specialty pharmaceutical-grade bulk antibiotics and is internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.

Alpharma press releases are also available at our website: http://www.alpharma.com.

SOURCE Alpharma Inc.